• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.11% Nasdaq Up0.17%

    Neogenomics Inc. (NEO)

    8.20 Up 0.10(1.23%) 11:32AM EST - Nasdaq Real Time Price
    ProfileGet Profile for:
    Neogenomics Inc.
    12701 Commonwealth Drive
    Suite 9
    Fort Myers, FL 33913
    United States - Map
    Phone: 239-768-0600
    Fax: 239-690-4237
    Website: http://www.neogenomics.org

    Index Membership:N/A
    Industry:Medical Laboratories & Research
    Full Time Employees:440

    Business Summary 

    NeoGenomics, Inc., together with its subsidiary, NeoGenomics Laboratories, Inc., operates a network of cancer-focused testing laboratories providing genetic and molecular testing services to hospitals, pathologists, oncologists, urologists, other clinicians and researchers, and other laboratories in the United States. The company performs analyses for hematopoietic cancers, such as leukemia and lymphoma; and solid tumor cancers comprising breast, lung, colon, and bladder cancer. It offers cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; immunohistochemistry testing services to localize proteins in cells of a tissue section; and molecular testing services that focus on the analysis of DNA and RNA, as well as on the structure and function of genes at the molecular level. The company was founded in 2001 and is headquartered in Fort Myers, Florida.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Neogenomics Inc.

    Corporate Governance 
    Neogenomics Inc.’s ISS Governance QuickScore as of Nov 1, 2015 is 6. The pillar scores are Audit: 2; Board: 7; Shareholder Rights: 2; Compensation: 9.
    Brought to you by Institutional Shareholder Services (ISS)

    Key Executives 
    Mr. Douglas M. Van Oort , 60
    Chairman and Chief Exec. Officer
    Mr. George A. Cardoza , 53
    Chief Financial Officer
    Mr. Robert J. Shovlin , 44
    Chief Operating Officer
    Mr. Steven A. Ross , 51
    Chief Information Officer
    Mr. Steven C. Jones , 52
    Chief Compliance Officer, Exec. VP of Fin., Director and Chairman of Compliance Committee
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders